Antibody-drug conjugates at AACR 2027
Apr 2–7, 2027 Orlando, FL ~23k attendees Website
18 organizations at AACR 2027 present work in antibody-drug conjugates: 11 drug developers and 7 tools, diagnostics, service and software companies. 18 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–18 of 18 organizations
| Organization | AACR 2027 Attendance |
|---|---|
AbbVie Mettawa, IL | |
Global biopharma whose cancer medicines include targeted drugs for blood cancers and antibody-drug conjugates for solid tumors. | Booth Exhibiting at Booth 2643 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Ambeed Buffalo Grove, IL | |
Supplier of small-molecule inhibitors, chemical building blocks, peptides, bioconjugation and PROTAC reagents, and custom synthesis for oncology drug discovery. | Booth Exhibiting at Booth 1557 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
AstraZeneca Cambridge, UK | |
Global biopharma with a large oncology portfolio spanning targeted therapies, antibody-drug conjugates and immunotherapies. | Booth Exhibiting at Booth 1943 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Biocytogen Beijing, China | |
Antibody discovery from humanized RenMice platforms, plus thousands of off-the-shelf humanized animal and cell models and preclinical pharmacology services. | Booth Exhibiting at Booth 2223 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
BioNTech Mainz, Germany | |
Biotechnology company covering research, drug discovery, clinical development, GMP manufacturing and commercialization, focused on oncology and infectious diseases. | Booth Exhibiting at Booth 2157 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Daiichi Sankyo Tokyo, Japan | |
Tokyo-based pharmaceutical company with roots in 1899, operating in 32 countries and aiming to become a global healthcare company by 2030. | Booth Exhibiting at Booth 2842 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Exelixis Alameda, CA | |
Oncology company known for cabozantinib, with a pipeline of small-molecule drugs, ADCs and biologics for a widening range of tumor types. | Booth Exhibiting at Booth 2825 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Genentech South San Francisco, CA | |
Roche Group member that discovers, develops, manufactures and markets medicines for serious and life-threatening conditions. | Booth Exhibiting at Booth 2243 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Genmab Copenhagen, Denmark | |
International biotechnology company developing antibody medicines for cancer and other serious diseases, with several wholly owned late-stage programs. | Booth Exhibiting at Booth 859 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Gilead and Kite Foster City, CA | |
Biopharmaceutical company developing medicines for cancer, HIV, viral hepatitis and other life-threatening diseases, exhibiting with Kite, its cell therapy company. | Booth Exhibiting at Booth 2431 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Glycogene Morrisville, NC | |
Supplier of ADC raw materials and nucleic acid and carbohydrate building blocks, with site-specific glycoengineering technology for next-generation ADC and antibody-oligonucleotide conjugates. | Booth Exhibiting at Booth 2878 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
GSK London, UK | |
Global drugmaker growing its oncology work in blood cancers, gynecologic cancers and other solid tumors through immuno-oncology and tumor-targeting medicines. | Booth Exhibiting at Booth 943 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Jubilant Biosys Yardley, PA | |
Contract research, development and manufacturing partner with sites in India and Europe, covering discovery chemistry and biology, DMPK, toxicology, ADCs and GMP APIs. | Booth Exhibiting at Booth 2375 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Merck Rahway, NJ | |
Drugmaker behind Keytruda, running one of the industry's largest oncology development programs across more than 30 tumor types; known as MSD abroad. | Booth Exhibiting at Booth 1929 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
NJ Bio Princeton, NJ | |
CRO/CDMO for antibody-drug conjugates and other bioconjugates: linker-payload chemistry, conjugation, bioanalysis, and in vitro and in vivo pharmacology and toxicology. | Booth Exhibiting at Booth 1301 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Pfizer New York, NY | |
Oncology unit with marketed and pipeline antibody-drug conjugates, small-molecule targeted drugs and bispecific immunotherapies across breast, genitourinary, hematologic, lung and other cancers. | Booth Exhibiting at Booth 1243 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Syngene Bangalore, India | |
Contract research, development and manufacturing partner for small molecules, biologics and ADCs, with protein-degrader and AI-driven discovery platforms. | Booth Exhibiting at Booth 2378 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Subsidiary of WuXi Biologics providing contract research, development and manufacturing for antibody-drug conjugates and other bioconjugates, from antibodies and payload-linkers to finished drug product. | Booth Exhibiting at Booth 2872 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Instantly find 20 buyers in antibody-drug conjugates
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse AACR 2027 by
Organization type
Focus
- Genomics and sequencing 82
- Imaging, spatial biology and pathology 59
- Drug discovery and screening 58
- Antibodies and recombinant proteins 52
- Tumor models and cell culture 45
- Immuno-oncology 36
- AI and data 28
- Single-cell analysis and flow cytometry 26
- Liquid biopsy 26
- Targeted therapy 21
- Clinical trials 21
- Proteomics and protein analysis 20
- Cell and gene therapy 19
- Antibody-drug conjugates 18
- Biospecimens and biobanking 17
Exhibit hall
Everyone
Not affiliated with the American Association for Cancer Research. Organization details are derived from AACR’s published exhibitor list. Submit a correction